Table 2 Attributions of lipids found as differentials between obese and non-obese individuals according to diffusion-edited 1H-NMR data.

From: Plasma lipid metabolites as potential biomarkers for identifying individuals at risk of obesity-induced metabolic complications

Fragment of the corresponding molecule

δ 1H identified (ppm)

1

–CH3

0.50–1.10

FA

0.5–0.8

Cholesterol esterified

0.8–1.1

2

–(CH2)n– FA

1.20–1.30

3

–CO–CH2–CH2

Cholesterol and FA (TAG, Phospholipids)

1.50–1.60

4

–CH2–CH=CH– (Allylic)

1.95–2.01

5

O–CO–CH2– (FA)

2.20–2.30

6

–CH2–CO–O–R (sn3 + sn1)

4.00–4.40

7

–CH–CO–O–R (sn2)

5.15–5.25

8

–CH=CH– (olefinic, UFA)

5.25–5.40

9

–CH2–CH=CH– (UFA)

2.01–2.07

10

–OOC–CH2–CH2 (FA)

2.33

11

–CH=CH–CH2–CH=CH–

2.67–2.76

12

Glycerol in TAG (2′-CHOCO–)

5.26

13

PUFA (9-cis, 11-cis) H9, H12 (–CH=)

5.40

14

PUFA (10-cis, 12-cis) H10, H13 (–CH=)

6.13

15

PUFA (10-cis, 12-cis) H11 (–CH=)

6.22

16

PUFA (9-cis, 11-cis) H10, H11 (–CH=)

6.22

17

PUFA (10-cis, 12-cis) H11, H12 (–CH=)

6.85

18

Phospholipids

FA (CH3–, –CH2– and other PUFA)

19

Phosphatidylcholines

3.18–3.21 (CH3)3N+); FA; (CH3–, –CH2– and other PUFA)

20

Phosphorylcholine

3.21; 3.58; 4.17

  1. FA Fatty acid, UFA unsaturated fatty acids, PUFA polyunsaturated fatty acids, TAG triacylglycerol.